Department of Hemato Oncology Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc Czech Republic

Department of Immunology Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc Czech Republic

Zobrazit více v PubMed

Coffey, D.G., Wu, Q.V., Towlerton, A.M.H., Ornelas, S., Morales, A.J., Xu, Y., Green, D.J. & Warren, E.H. (2019) Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma. Blood Cancer Journal, 9, 77.

Kumar, S.K., Callander, N.S., Alsina, M., Atanackovic, D., Biermann, J., Chandler, J.C., Costello, C., Faiman, M., Fung, H.C., Gasparetto, C., Godby, K., Hofmeister, C., Holmberg, L., Holstein, S., Huff, C., Kassim, A., Liedtke, M., Martin, T., Omel, J., Raje, N., Reu, F.J., Singhal, S., Somlo, G., Stockerl-Goldstein, K., Treon, S.P., Weber, D., Yahalom, J., Shead, D.A. & Kumar, R. (2017) Multiple myeloma, version 3.2017, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 15, 230-269.

Lakshman, A., Painuly, U., Rajkumar, S.V., Ketterling, R.P., Kapoor, P., Greipp, P.T., Gertz, M.A., Buadi, F.K., Lacy, M.Q., Dingli, D., Dispenzieri, A., Fonder, A.L., Hayman, S.R., Hobbs, M.A., Gonsalves, W.I., Hwa, Y.L., Leung, N., Go, R.S., Lin, Y., Kourelis, T.V., Warsame, R., Lust, J.A., Russell, S.J., Zeldenrust, S.R., Kyle, R.A. & Kumar, S.K. (2019) Natural history of multiple myeloma with de novo del(17p). Blood Cancer Journal, 9, 32.

Manier, S., Salem, K.Z., Park, J., Landau, D.A., Getz, G. & Ghobrial, I.M. (2017) Genomic complexity of multiple myeloma and its clinical implications. Nature Reviews Clinical Oncology, 14, 100-113.

Mansilla, C., Soria, E., Vallejo, M., Valiente, A., Perez-Juana, A., Zabalza, A., Hurtado, G., Sala, F. & Ramírez, N. (2018) Combined selection system to lower the cutoff for plasma cell enrichment applied to iFISH analysis in multiple myeloma. Translational oncology, 11, 647-652.

Mlynarcikova, M., Balcarkova, J., Mickova, P., Scudla, V., Pika, T., Bacovsky, J., Minarik, J., Janousova, E. & Jarosova, M. (2016) Molecular cytogenetic analysis of chromosome 8 aberrations in patients with multiple myeloma examined in 2 different stages, at diagnosis and at progression/relapse. Clinical Lymphoma Myeloma and Leukemia, 16, 358-365.

Obr, A., Procházka, V., Jirkuvová, A., Urbánková, H., Kriegova, E., Schneiderová, P., Vatolíková, M. & Papajík, T. (2018) TP53 mutation and complex karyotype portends a dismal prognosis in patients with mantle cell lymphoma. Clinical Lymphoma Myeloma and Leukemia, 18, 762-768.

Petrackova, A., Vasinek, M., Sedlarikova, L., Dyskova, T., Schneiderova, P., Novosad, T., Papajik, T. & Kriegova, E. (2019) Standardization of sequencing coverage depth in NGS: recommendation for detection of clonal and subclonal mutations in cancer diagnostics. Frontiers in Oncology, 9, 851.

Romano, A., Palumbo, G.A., Parrinello, N.L., Conticello, C., Martello, M. & Terragna, C. (2019) Minimal residual disease assessment within the bone marrow of multiple myeloma: a review of caveats, clinical significance and future perspectives. Frontiers in oncology, 9, 699.

Ross, F.M., Avet-Loiseau, H., Ameye, G., Gutiérrez, N.C., Liebisch, P., O'Connor, S., Dalva, K., Fabris, S., Testi, A.M., Jarosova, M., Hodkinson, C., Collin, A., Kerndrup, G., Kuglik, P., Ladon, D., Bernasconi, P., Maes, B., Zemanova, Z., Michalova, K., Michau, L., Neben, K., Hermansen, N.E., Rack, K., Rocci, A., Protheroe, R., Chiecchio, L., Poirel, H.A., Sonneveld, P., Nyegaard, M. & Johnsen, H.E. (2012) Report from the European myeloma network on interphase FISH in multiple myeloma and related disorders. Haematologica, 97, 1272-1277.

Ryland, G.L., Jones, K., Chin, M., Markham, J., Aydogan, E., Kankanige, Y., Caruso, M., Guinto, J., Dickinson, M., Prince, H.M., Yong, K. & Blombery, P. (2018) Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing. Journal of Clinical Pathology, 71, 895-899.

Salk, J.J., Schmitt, M.W. & Loeb, L.A. (2018) Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations. Nature Reviews Genetics, 19, 269-285.

Thakurta, A., Ortiz, M., Blecua, P., Towfic, F., Corre, J., Serbina, N.V., Flynt, E., Yu, Z., Yang, Z., Palumbo, A., Dimopoulos, M.A., Gutierrez, N.C., Goldschmidt, H., Sonneveld, P. & Avet-Loiseau, H. (2019) High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma. Blood, 133, 1217-1221.

Vikova, V., Jourdan, M., Robert, N., Requirand, G., Boireau, S., Bruyer, A., Vincent, L., Cartron, G., Klein, B., Elemento, O., Kassambara, A. & Moreaux, J. (2019) Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance. Theranostics, 9, 540-553.

Walker, B.A., Mavrommatis, K., Wardell, C.P., Ashby, T.C., Bauer, M., Davies, F.E., Rosenthal, A., Wang, H., Qu, P., Hoering, A., Samur, M., Towfic, F., Ortiz, M., Flynt, E., Yu, Z., Yang, Z., Rozelle, D., Obenauer, J., Trotter, M., Auclair, D., Keats, J., Bolli, N., Fulciniti, M., Szalat, R., Moreau, P., Durie, B., Stewart, A.K., Goldschmidt, H., Raab, M.S., Einsele, H., Sonneveld, P., San Miguel, J., Lonial, S., Jackson, G.H., Anderson, K.C., Avet-Loiseau, H., Munshi, N., Thakurta, A. & Morgan, G.J. (2019) A high-risk, double-hit, group of newly diagnosed myeloma identified by genomic analysis. Leukemia, 33, 159-170.

Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities